Abstract

Japan’s Otsuka Chemical is entering the active pharmaceutical ingredient (API) market by acquiring part of Astellas Pharma’s cefixime business. Developed by Astellas, cefixime is a third-generation...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call